Blue Jet Healthcare's Q1 Financial Results Show Decline in Key Areas

Aug 06 2024 02:32 PM IST
share
Share Via
Blue Jet Healthcare, a midcap medical equipment company, reported its financial results for the quarter ending March 2024 on August 6, 2024. The results received a 'Hold' call from MarketsMojo. The company's overall financial health has declined, with negative performance in key areas such as PBT, PAT, net sales, and operating profit. Investors are advised to hold their stock for now.

Blue Jet Healthcare, a midcap company in the medical equipment industry, recently announced its financial results for the quarter ending March 2024. The results, declared on August 6, 2024, have received a 'Hold' call from MarketsMOJO.

According to the financials, Blue Jet Health has seen a negative performance in the quarter, with a score of -9 compared to -5 in the previous three months. This indicates a decline in the company's overall financial health.

One of the major factors contributing to this decline is the Profit Before Tax less Other Income (PBT) which has fallen by 18.9% to Rs 40.75 crore from an average of Rs 50.25 crore in the previous four quarters. The trend for PBT in the near term is also negative.

Similarly, the Profit After Tax (PAT) has also seen a decline of 11.6% to Rs 37.78 crore from an average of Rs 42.73 crore in the previous four quarters. The company's net sales have also taken a hit, with the lowest figure of Rs 162.90 crore in the last five quarters. The near term trend for net sales is also negative, with a decline of 8.4% from the average of Rs 177.90 crore in the previous four quarters.

The Operating Profit (PBDIT) has also seen a decline, with the lowest figure of Rs 44.26 crore in the last five quarters. The Operating Profit Margin has also hit its lowest point at 27.17%, indicating a deterioration in the company's efficiency.

Overall, the financial results for the quarter ending March 2024 have not been favorable for Blue Jet Healthcare. The company's performance has seen a decline in key areas, and the near term trend is also negative. Investors are advised to hold their stock in the company for now.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News